Medline, Inc. (MDLN)
39.17
-0.30
(-0.76%)
USD |
NASDAQ |
Nov 16, 16:00
38.43
-0.74
(-1.89%)
After-Hours: 04:59
Medline Enterprise Value : 51.05B for Nov. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 51.05B |
| November 13, 2026 | 51.32B |
| November 12, 2026 | 51.77B |
| November 11, 2026 | 53.68B |
| November 10, 2026 | 52.58B |
| November 09, 2026 | 52.41B |
| November 06, 2026 | 51.47B |
| November 05, 2026 | 51.57B |
| November 04, 2026 | 52.09B |
| November 03, 2026 | 46.59B |
| November 02, 2026 | 46.18B |
| October 30, 2026 | 44.86B |
| October 29, 2026 | 44.75B |
| October 28, 2026 | 45.08B |
| October 27, 2026 | 45.09B |
| October 26, 2026 | 46.24B |
| October 23, 2026 | 46.59B |
| October 22, 2026 | 47.28B |
| October 21, 2026 | 47.66B |
| October 20, 2026 | 47.79B |
| October 19, 2026 | 47.56B |
| October 16, 2026 | 48.23B |
| October 15, 2026 | 48.77B |
| October 14, 2026 | 48.21B |
| October 13, 2026 | 48.00B |
| Date | Value |
|---|---|
| October 12, 2026 | 48.06B |
| October 09, 2026 | 48.50B |
| October 08, 2026 | 48.04B |
| October 07, 2026 | 47.78B |
| October 06, 2026 | 47.87B |
| October 05, 2026 | 48.09B |
| October 02, 2026 | 47.92B |
| October 01, 2026 | 47.34B |
| September 30, 2026 | 47.12B |
| September 29, 2026 | 48.14B |
| September 28, 2026 | 48.22B |
| September 25, 2026 | 47.90B |
| September 24, 2026 | 47.86B |
| September 23, 2026 | 47.55B |
| September 22, 2026 | 47.66B |
| September 21, 2026 | 45.49B |
| September 18, 2026 | 45.21B |
| September 17, 2026 | 45.64B |
| September 16, 2026 | 46.40B |
| September 15, 2026 | 45.63B |
| September 14, 2026 | 46.05B |
| September 11, 2026 | 45.99B |
| September 10, 2026 | 45.87B |
| September 09, 2026 | 47.33B |
| September 08, 2026 | 47.89B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 213.55B |
| AngioDynamics, Inc. | 476.53M |
| Alphatec Holdings, Inc. | 1.578B |
| AtriCure, Inc. | 2.726B |
| Baxter International, Inc. | 19.22B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 321.00M |
| Revenue (Quarterly) | 7.856B |
| Total Expenses (Quarterly) | 7.658B |
| EPS Diluted (Quarterly) | 0.2188 |
| Gross Profit Margin (Quarterly) | 22.26% |
| Profit Margin (Quarterly) | 4.09% |
| Earnings Yield | 1.71% |
| Operating Earnings Yield | 5.31% |
| Normalized Earnings Yield | 3.116 |